During the past decade, Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics" #1 collaborator was "University of California, San Diego" with 3 trials as a collaborator, "Sanprobi" with 1 trials as a collaborator and "Yale University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics" are "PCOS" (2 trials), "PCOS, Insulin Resistance" (1 trials) and "Polycystic Ovary Syndrome" (1 trials). Many other conditions were trialed in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics" in a lesser frequency.

Most popular intervention types in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics" are "Drug" (3 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dietary and life style modification and probiotic Sanprobi Super Formula" (1 trials), "MetFORMIN 500 Mg Oral Tablet" (1 trials), "Placebo" (1 trials), "Simvastatin and micronized trans-resveratrol" (1 trials) and "simvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".